Likely Diagnosis: Tactile Hallucinations or Formication
This patient is experiencing tactile hallucinations (formication - the sensation of insects crawling on the skin) which is most likely a manifestation of inadequately treated psychiatric illness, though medication-induced akathisia or a rare adverse effect must also be considered.
Differential Diagnosis & Evaluation
The sensation of "ants crawling on the face" without visible insects represents formication, which has three primary etiologies in this context:
Psychotic symptoms from underlying psychiatric disorder (most likely)
- Inadequate treatment response to current regimen
- Breakthrough psychotic symptoms despite medication
- Consider if patient has schizophrenia, bipolar disorder, or psychotic depression
Medication-induced akathisia
Delusional infestation (less likely given existing psychiatric treatment)
Recommended Management Algorithm
Step 1: Assess Current Medication Adequacy
Evaluate aripiprazole dosing:
- The optimal dose for augmentation is 2-5 mg/day based on dose-effect meta-analysis 4
- Higher doses (up to 20 mg) show no additional efficacy benefit 4
- If patient is on suboptimal dosing, adjust within this range
Verify sertraline adequacy:
- Ensure patient is on therapeutic dose (typically 100 mg/day for augmentation studies) 5, 1
- Confirm adequate trial duration (at least 8 weeks at therapeutic dose)
Step 2: Rule Out Akathisia
Examine for:
- Inner restlessness or inability to sit still
- Pacing behavior
- Anxiety that worsens with inactivity
If akathisia is present:
- Administer diphenhydramine 50 mg orally for immediate relief 2
- Consider dose reduction or medication change
- Note: Only 2.2% of patients discontinue aripiprazole due to adverse effects, and akathisia rarely leads to discontinuation 1
Step 3: Optimize Current Regimen
If tactile hallucinations persist and akathisia is ruled out:
The combination of aripiprazole with sertraline is evidence-based and effective 5, 6, 1. However, if symptoms persist:
- Increase aripiprazole to optimal augmentation dose (2-5 mg/day if below this range) 4
- Response typically occurs within 1-5 weeks 7
- Monitor for 6 weeks minimum before declaring treatment failure 5, 1
Step 4: Consider Treatment Resistance
If inadequate response after optimized dosing for 6 weeks:
- Reassess primary diagnosis - tactile hallucinations may indicate more severe psychotic features requiring different treatment approach
- Consider switching from augmentation strategy to antipsychotic monotherapy at higher doses
- Evaluate for clozapine candidacy if schizophrenia diagnosis
- Refer to psychiatry if not already involved
Critical Safety Monitoring
Monitor for serious adverse effects 8:
- Akathisia (most common, 23.1% incidence) 1
- Extrapyramidal symptoms including oculogyric crisis (rare but serious) 2
- Metabolic changes (weight gain, diabetes)
- Suicidal ideation (black box warning for antidepressants in young adults) 8
Common Pitfalls to Avoid
Assuming all sensory symptoms are medication side effects - tactile hallucinations are more likely breakthrough psychotic symptoms requiring treatment optimization, not medication discontinuation
Using excessive aripiprazole doses - doses above 5 mg show no additional efficacy benefit for augmentation 4
Premature medication changes - allow 6 weeks at therapeutic doses before declaring treatment failure 5, 1
Confusing akathisia with psychotic agitation - akathisia responds rapidly to anticholinergics like diphenhydramine 2
Overlooking medication adherence - verify patient is actually taking medications as prescribed before escalating treatment